| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7B | $4.4B | $4.4B | $4.4B | $4.8B | $3.3B | $3.1B | $3.1B |
| Cost of Revenue | $2.1B | $2.0B | $1.9B | $1.9B | $2.1B | $0.6B | $0.4B | $0.4B |
| Gross Profit | $2.6B | — | — | — | — | — | — | — |
| R&D Expense | $0.4B | $0.3B | $0.3B | $0.3B | $0.4B | $0.3B | $0.3B | $0.2B |
| SG&A Expense | $1.4B | $1.3B | $1.3B | $1.3B | $1.4B | $1.0B | $0.8B | $0.7B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.2B | $0.3B | $-1.2B | $-0.1B | $-0.5B | $-0.3B | $-0.0B | $0.0B |
| EPS (Basic) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.97 | $-1.27 | $0.18 | — |
| EPS (Diluted) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.97 | $-1.27 | $0.18 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.4B | $12.6B | $14.4B | $15.5B | $16.5B | $17.7B | $9.0B | $9.0B |
| Current Assets | $3.5B | $3.2B | $3.4B | $3.3B | $3.3B | $3.4B | $2.4B | $2.5B |
| Cash & Equivalents | $0.5B | $0.5B | $0.4B | $0.3B | $0.6B | $0.5B | $0.3B | $0.5B |
| Total Liabilities | $6.8B | $6.5B | $8.1B | $8.2B | $8.9B | $9.2B | $3.4B | $3.8B |
| Current Liabilities | $1.6B | $1.3B | $1.2B | $1.7B | $1.6B | $2.1B | $0.8B | $1.0B |
| Stockholders' Equity | $6.5B | $6.1B | $6.2B | $7.3B | $7.5B | $8.5B | $5.5B | $5.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.3B | $0.5B | $0.5B | $-0.0B | $0.2B | $0.5B |
| Investing Cash Flow | $-0.3B | $1.2B | $-0.2B | $-0.2B | $-0.5B | $-4.8B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.3B | $-1.5B | $-0.1B | $-0.5B | $0.2B | $5.0B | $-0.3B | $-0.0B |